Top

Published in:

15-03-2024 | Inflammatory Rheumatic Diseases | Review

Exploring complex links: inflammatory rheumatic diseases and men's health

Authors: Burhan Fatih Kocyigit, Yuliya Fedorchenko, Kassymkhan Sultanbekov, Gulsah Yasa Ozturk, Marlen Yessirkepov

Published in: Rheumatology International | Issue 5/2024

Abstract

This article examines the complex interactions between inflammatory rheumatic diseases (IRDs) and men's health. It delves into the effects of IRDs on reproductive health, erectile dysfunction, prostate involvement, male osteoporosis, body composition, physical activity, and coping mechanisms. The findings show that the prevalence of sexual dysfunction varies among different diseases, underscoring the necessity for comprehensive counseling. The link between IRDs and prostate health, with a substantial rise in benign prostatic hyperplasia among IRD patients, demonstrates the condition's importance. In contrast to popular belief, osteoporosis mostly affects women; the current study highlights the growing identification of male osteoporosis, particularly in the setting of IRDs. Male RA patients had a significant loss in bone mineral density, highlighting the importance of increasing awareness and tailored therapy to address osteoporosis in men. IRDs affect body composition, with male RA patients showing imbalances characterized by decreased lean body mass and increased fat mass. Given the dynamic nature of these conditions, coping with IRDs necessitates thorough and individualized diversified approaches. The complex link between IRDs and men's health demands continuing research, including longitudinal studies and tailored therapies. The essay promotes a patient-centered approach, recognizing the unique obstacles that males with IRDs confront.

Cuervo FM, Santos AM, Londono J et al (2022) The burden of the most common rheumatic disease in Colombia. BMC Rheumatol 6:7. https://doi.org/10.1186/s41927-021-00234-yCrossRefPubMedPubMedCentral

Al Maini M, Adelowo F, Al Saleh J et al (2015) The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases. Clin Rheumatol 34:819–829. https://doi.org/10.1007/s10067-014-2841-6CrossRefPubMed

Doukas C, Saltiki K, Mantzou A, Cimponeriu A, Terzidis K, Sarika L, Mavrikakis M, Sfikakis P, Alevizaki M (2013) Hormonal parameters and sex hormone receptor gene polymorphisms in men with autoimmune diseases. Rheumatol Int 33:575–582. https://doi.org/10.1007/s00296-012-2386-4CrossRefPubMed

Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS (2020) Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int 40:1539–1554. https://doi.org/10.1007/s00296-020-04639-9CrossRefPubMedPubMedCentral

Adelowo O, Mody GM, Tikly M, Oyoo O, Slimani S (2021) Rheumatic diseases in Africa. Nat Rev Rheumatol 17:363–374. https://doi.org/10.1038/s41584-021-00603-4CrossRefPubMedPubMedCentral

Baker P (2018) Men’s health: time for a new approach. Phys Ther Rev 23:144–150. https://doi.org/10.1080/10833196.2018.1452562CrossRef

Nuzzo JL (2020) Men’s health in the United States: a national health paradox. Aging Male 23:42–52. https://doi.org/10.1080/13685538.2019.1645109CrossRefPubMed

Sakkas LI, Chikanza IC (2023) Sex bias in immune response: it is time to include the sex variable in studies of autoimmune rheumatic diseases. Rheumatol Int. https://doi.org/10.1007/s00296-023-05446-8CrossRefPubMed

Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409–1417. https://doi.org/10.1007/s00296-011-1999-3CrossRefPubMed

10.

Fraczek M, Kurpisz M (2015) Cytokines in the male reproductive tract and their role in infertility disorders. J Reprod Immunol 108:98–104. https://doi.org/10.1016/j.jri.2015.02.001CrossRefPubMed

11.

Loveland KL, Klein B, Pueschl D, Indumathy S, Bergmann M, Loveland BE, Hedger MP, Schuppe HC (2017) Cytokines in Male Fertility and Reproductive Pathologies: Immunoregulation and Beyond. Front Endocrinol (Lausanne) 8:307. https://doi.org/10.3389/fendo.2017.00307CrossRefPubMed

12.

Gregory M, Cyr DG (2014) The blood-epididymis barrier and inflammation. Spermatogenesis. https://doi.org/10.4161/21565562.2014.979619CrossRefPubMedPubMedCentral

13.

El Miedany Y, El Gaafary M, El Aroussy N, Youssef S, Ahmed I (2012) Sexual dysfunction in rheumatoid arthritis patients: arthritis and beyond. Clin Rheumatol 31:601–606. https://doi.org/10.1007/s10067-011-1891-2CrossRefPubMed

14.

van Berlo WT, van de Wiel HB, Taal E, Rasker JJ, Weijmar Schultz WC, van Rijswijk MH (2007) Sexual functioning of people with rheumatoid arthritis: a multicenter study. Clin Rheumatol 26:30–38. https://doi.org/10.1007/s10067-006-0216-3CrossRefPubMed

15.

Tengstrand B, Carlström K, Hafström I (2009) Gonadal hormones in men with rheumatoid arthritis–from onset through 2 years. J Rheumatol 36:887–892. https://doi.org/10.3899/jrheum.080558CrossRefPubMed

16.

Wilton KM, Achenbach SJ, Davis JM 3rd, Myasoedova E, Matteson EL, Crowson CS (2021) Erectile Dysfunction and Cardiovascular Risk in Men With Rheumatoid Arthritis: A Population-based Cohort Study. J Rheumatol 48:1641–1647. https://doi.org/10.3899/jrheum.201226CrossRefPubMedPubMedCentral

17.

Rostom S, Mengat M, Mawani N, Jinane H, Bahiri R, Hajjaj-Hassouni N (2013) Sexual activity in Moroccan men with ankylosing spondylitis. Rheumatol Int 33:1469–1474. https://doi.org/10.1007/s00296-012-2535-9CrossRefPubMed

18.

Sariyildiz MA, Batmaz I, Dilek B, Inanir A, Bez Y, Tahtasiz M, Em S, Cevik R (2013) Relationship of the sexual functions with the clinical parameters, radiological scores and the quality of life in male patients with ankylosing spondylitis. Rheumatol Int 33:623–629. https://doi.org/10.1007/s00296-012-2432-2CrossRefPubMed

19.

Cakar E, Dincer U, Kiralp MZ, Taskaynatan MA, Yasar E, Bayman EO, Ozgul A, Dursun H (2007) Sexual problems in male ankylosing spondylitis patients: relationship with functionality, disease activity, quality of life, and emotional status. Clin Rheumatol 26:1607–1713. https://doi.org/10.1007/s10067-007-0545-xCrossRefPubMed

20.

Ramonda R, Foresta C, Ortolan A, Bertoldo A, Oliviero F, Lorenzin M, Pizzol D, Punzi L, Garolla A (2014) Influence of tumor necrosis factor α inhibitors on testicular function and semen in spondyloarthritis patients. Fertil Steril 101:359–365. https://doi.org/10.1016/j.fertnstert.2013.10.048CrossRefPubMed

21.

Nukumizu LA, GonçalvesSaad C, Ostensen M, Almeida BP, Cocuzza M, Gonçalves C, Saito O, Bonfá E, Silva CA (2012) Gonadal function in male patients with ankylosing spondylitis. Scand J Rheumatol 41:476–481CrossRefPubMed

22.

Almeida BP, Saad CG, Souza FH, Moraes JC, Nukumizu LA, Viana VS, Bonfá E, Silva CA (2013) Testicular Sertoli cell function in ankylosing spondylitis. Clin Rheumatol 32:1075–1079. https://doi.org/10.1007/s10067-013-2215-5CrossRefPubMed

23.

Merayo-Chalico J, Barrera-Vargas A et al (2019) Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American Landscape. J Rheumatol 46:397–404. https://doi.org/10.3899/jrheum.180292CrossRefPubMed

24.

Vecchi AP, Borba EF, Bonfá E, Cocuzza M, Pieri P, Kim CA, Silva CA (2011) Penile anthropometry in systemic lupus erythematosus patients. Lupus 20:512–518. https://doi.org/10.1177/0961203310384121CrossRefPubMed

25.

Soares PM, Borba EF, Bonfa E, Hallak J, Corrêa AL, Silva CA (2007) Gonad evaluation in male systemic lupus erythematosus. Arthritis Rheum 56:2352–2361. https://doi.org/10.1002/art.22660CrossRefPubMed

26.

Suehiro RM, Borba EF, Bonfa E, Okay TS, Cocuzza M, Soares PM, Silva CA (2008) Testicular Sertoli cell function in male systemic lupus erythematosus. Rheumatology (Oxford) 47:1692–1697. https://doi.org/10.1093/rheumatology/ken338CrossRefPubMed

27.

Tiseo BC, Bonfá E, Borba EF, Munhoz GA, Wood G, Srougi M, Silva CA, Cocuzza M (2019) Complete urological evaluation including sperm DNA fragmentation in male systemic lupus erythematosus patients. Lupus 28:59–65. https://doi.org/10.1177/0961203318815764CrossRefPubMed

28.

Ostojic P, Damjanov N (2007) The impact of depression, microvasculopathy, and fibrosis on development of erectile dysfunction in men with systemic sclerosis. Clin Rheumatol 26:1671–1674. https://doi.org/10.1007/s10067-007-0567-4CrossRefPubMed

29.

Foocharoen C, Tyndall A, Hachulla E et al (2012) Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group. Arthritis Res Ther 14:R37. https://doi.org/10.1186/ar3748CrossRefPubMedPubMedCentral

30.

Erdoğru T, Koçak T, Serdaroğlu P, Kadioğlu A, Tellaloğlu S (1999) Evaluation and therapeutic approaches of voiding and erectile dysfunction in neurological Behçet’s syndrome. J Urol 162:147–153. https://doi.org/10.1097/00005392-199907000-00036CrossRefPubMed

31.

Hiz O, Ediz L, Gülcü E, Tekeoglu I (2011) Effects of Behçet’s disease on sexual function and psychological status of male patients. J Sex Med 8:1426–1433. https://doi.org/10.1111/j.1743-6109.2010.02040.xCrossRefPubMed

32.

Gül IG, Kartalcı Ş, Cumurcu BE, Karıncaoğlu Y, Yoloğlu S, Karlıdağ R (2013) Evaluation of sexual function in patients presenting with Behçet’s disease with or without depression. J Eur Acad Dermatol Venereol 27:1244–1251. https://doi.org/10.1111/j.1468-3083.2012.04698.xCrossRefPubMed

33.

Luo L, Xiang Q, Deng Y, Zhao S, Zhu Z, Liu Y, Wang J, Zhao Z (2019) Gout is associated with elevated risk of erectile dysfunction: a systematic review and meta-analysis. Rheumatol Int 39:1527–1535. https://doi.org/10.1007/s00296-019-04365-xCrossRefPubMed

34.

Richter JG, Becker A, Specker C, Schneider M (2008) Hypogonadism in Wegener’s granulomatosis. Scand J Rheumatol 37:365–369. https://doi.org/10.1080/03009740801998796CrossRefPubMed

35.

Tuin J, Sanders JS, Buhl BM, van Beek AP, Stegeman CA (2013) Androgen deficiency in male patients diagnosed with ANCA-associated vasculitis: a cause of fatigue and reduced health-related quality of life? Arthritis Res Ther 15:R117. https://doi.org/10.1186/ar4297CrossRefPubMedPubMedCentral

36.

Perez-Garcia LF, Röder E, Goekoop RJ et al (2021) Impaired fertility in men diagnosed with inflammatory arthritis: results of a large multicentre study (iFAME-Fertility). Ann Rheum Dis 80:1545–1552. https://doi.org/10.1136/annrheumdis-2021-220709CrossRefPubMed

37.

Verze P, Cai T, Lorenzetti S (2016) The role of the prostate in male fertility, health and disease. Nat Rev Urol 13:379–386. https://doi.org/10.1038/nrurol.2016.89CrossRefPubMed

38.

Bushman WA, Jerde TJ (2016) The role of prostate inflammation and fibrosis in lower urinary tract symptoms. Am J Physiol Renal Physiol 311:F817–F821. https://doi.org/10.1152/ajprenal.00602.2015CrossRefPubMed

39.

Fowke JH, Koyama T, Fadare O, Clark PE (2016) Does Inflammation Mediate the Obesity and BPH Relationship? An Epidemiologic Analysis of Body Composition and Inflammatory Markers in Blood, Urine, and Prostate Tissue, and the Relationship with Prostate Enlargement and Lower Urinary Tract Symptoms. PLoS ONE. https://doi.org/10.1371/journal.pone.0156918CrossRefPubMedPubMedCentral

40.

Parsons JK, Sarma AV, McVary K, Wei JT (2013) Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol 189:S102-106. https://doi.org/10.1016/j.juro.2012.11.029CrossRefPubMed

41.

Vickman RE, Aaron-Brooks L, Zhang R et al (2022) TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease. Nat Commun 13:2133. https://doi.org/10.1038/s41467-022-29719-1CrossRefPubMedPubMedCentral

42.

Tzeng YM, Kao LT, Lin HC, Huang CY (2015) A Population-Based Study on the Association between Benign Prostatic Enlargement and Rheumatoid Arthritis. PLoS ONE. https://doi.org/10.1371/journal.pone.0133013CrossRefPubMedPubMedCentral

43.

Ou J, Zou L, Wu Y, Zhang Q, Fang Y, Qiu M, Tian X, Ma L, Bi H, Liu C (2023) Causal inference between rheumatoid arthritis and prostate cancer. Clin Exp Med 23:4681–4694. https://doi.org/10.1007/s10238-023-01151-9CrossRefPubMed

44.

Yatsyshyn R, Zimba O, Bahrii M, Doskaliuk B, Huryk V (2019) Prostate involvement in granulomatosis with polyangiitis. Rheumatol Int 39:1269–1277. https://doi.org/10.1007/s00296-019-04321-9CrossRefPubMed

45.

Liu H, Wallace ZS, Harvey L, Crotty R, Wu CL, Deshpande V, O’Shea A, Harisinghani M, Ghebremichael M, Nehra A, Stone JH, Perugino CA (2020) Prostate and pancreas involvement are linked in IgG4-related disease. Semin Arthritis Rheum 50:1245–1251. https://doi.org/10.1016/j.semarthrit.2020.09.002CrossRefPubMed

46.

Loures MAR, Zerbini CAF, Danowski JS, Pereira RMR, Moreira C, Paula AP, Castro CHM, Szejnfeld VL, Mendonça LMC, Radominiski SC, Bezerra MC, Simões R, Bernardo WM (2017) Guidelines of the Brazilian Society of Rheumatology for the diagnosis and treatment of osteoporosis in men. Rev Bras Reumatol Engl Ed 57(Suppl 2):497–514. https://doi.org/10.1016/j.rbre.2017.07.003CrossRefPubMed

47.

Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7:407–413. https://doi.org/10.1007/pl00004148CrossRefPubMed

48.

Willson T, Nelson SD, Newbold J, Nelson RE, LaFleur J (2015) The clinical epidemiology of male osteoporosis: a review of the recent literature. Clin Epidemiol 7:65–76. https://doi.org/10.2147/CLEP.S40966CrossRefPubMedPubMedCentral

49.

Nolla JM, Roig-Vilaseca D, Gomez-Vaquero C, Mateo L, Juanola X, Rodriguez-Moreno J, Narvaez J, Valverde J (2006) Frequency of osteoporosis in 187 men with rheumatoid arthritis followed in a university hospital. J Rheumatol 33:1472–1475PubMed

50.

Kweon SM, Sohn DH, Park JH, Koh JH, Park EK, Lee HN, Kim K, Kim Y, Kim GT, Lee SG (2018) Male patients with rheumatoid arthritis have an increased risk of osteoporosis: Frequency and risk factors. Medicine (Baltimore). https://doi.org/10.1097/MD.0000000000011122CrossRefPubMedPubMedCentral

51.

Theander L, Jacobsson LTH, Turesson C (2023) Osteoporosis-related fractures in men and women with established and early rheumatoid arthritis: predictors and risk compared with the general population. BMC Rheumatol 7:28. https://doi.org/10.1186/s41927-023-00354-7CrossRefPubMedPubMedCentral

52.

Kramer HR, Fontaine KR, Bathon JM, Giles JT (2012) Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes. Arthritis Rheum 64:2438–2450. https://doi.org/10.1002/art.34464CrossRefPubMedPubMedCentral

53.

Müller R, Kull M, Põlluste K, Valner A, Lember M, Kallikorm R (2019) Factors Associated With Low Lean Mass in Early Rheumatoid Arthritis: A Cross- Sectional Study. Medicina (Kaunas) 55:730. https://doi.org/10.3390/medicina55110730CrossRefPubMed

54.

Giles JT, Allison M, Blumenthal RS, Post W, Gelber AC, Petri M, Tracy R, Szklo M, Bathon JM (2010) Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum 62:3173–3182. https://doi.org/10.1002/art.27629CrossRefPubMedPubMedCentral

55.

Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, Kitas GD (2011) Obesity in rheumatoid arthritis. Rheumatology (Oxford) 50:450–462. https://doi.org/10.1093/rheumatology/keq266CrossRefPubMed

56.

Katz PP, Yazdany J, Trupin L, Schmajuk G, Margaretten M, Barton J, Criswell LA, Yelin EH (2013) Sex differences in assessment of obesity in rheumatoid arthritis. Arthritis Care Res (Hoboken) 65:62–70. https://doi.org/10.1002/acr.21810CrossRefPubMed

57.

Baker JF, Long J, Ibrahim S, Leonard MB, Katz P (2015) Are men at greater risk of lean mass deficits in rheumatoid arthritis? Arthritis Care Res (Hoboken) 67:112–119. https://doi.org/10.1002/acr.22396CrossRefPubMed

58.

Nikiphorou E, Santos EJF, Marques A et al (2021) 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. Ann Rheum Dis 80:1278–1285. https://doi.org/10.1136/annrheumdis-2021-220249CrossRefPubMed

59.

Clarke LH, Bennett E (2013) “You learn to live with all the things that are wrong with you”: gender and the experience of multiple chronic conditions in later life. Ageing Soc 33:342–360. https://doi.org/10.1017/S0144686X11001243CrossRefPubMed

60.

Hammer NM, Midtgaard J, Hetland ML, Krogh NS, Esbensen BA (2018) Physical activity behaviour in men with inflammatory joint disease: a cross-sectional register-based study. Rheumatology (Oxford) 57:803–812. https://doi.org/10.1093/rheumatology/kex498CrossRefPubMed

61.

Flurey CA, Hewlett S, Rodham K, White A, Noddings R, Kirwan J (2016) Men, rheumatoid arthritis, psychosocial impact and self-management: A narrative review. J Health Psychol 21:2168–2182. https://doi.org/10.1177/1359105315572452CrossRefPubMed

62.

van Lunteren M, Scharloo M, Ez-Zaitouni Z, de Koning A, Landewé R, Fongen C, Ramonda R, Kaptein AA, van Gaalen FA, van der Heijde D (2018) The Impact of Illness Perceptions and Coping on the Association Between Back Pain and Health Outcomes in Patients Suspected of Having Axial Spondyloarthritis: Data From the SPondyloArthritis Caught Early Cohort. Arthritis Care Res (Hoboken) 70:1829–1839. https://doi.org/10.1002/acr.23566CrossRefPubMed

63.

Flurey CA, Hewlett S, Rodham K, White A, Noddings R, Kirwan JR (2016) Identifying different typologies of experiences and coping strategies in men with rheumatoid arthritis: a Q-methodology study. BMJ Open. https://doi.org/10.1136/bmjopen-2016-012051CrossRefPubMedPubMedCentral

64.

Flurey CA, Hewlett S, Rodham K, White A, Noddings R, Kirwan JR (2018) Coping Strategies, Psychological Impact, and Support Preferences of Men With Rheumatoid Arthritis: A Multicenter Survey. Arthritis Care Res (Hoboken) 70:851–860. https://doi.org/10.1002/acr.23422CrossRefPubMed

65.

Flurey CA, Pauling JD, Saketkoo LA, Denton CP, Galdas P, Khanna D, Williams A, Hughes M (2023) “I turned in my man card”: a qualitative study of the experiences, coping styles and support needs of men with systemic sclerosis. Rheumatology (Oxford) 62:2160–2167. https://doi.org/10.1093/rheumatology/keac585CrossRefPubMed

Title: Exploring complex links: inflammatory rheumatic diseases and men's health
Authors: Burhan Fatih Kocyigit
Yuliya Fedorchenko
Kassymkhan Sultanbekov
Gulsah Yasa Ozturk
Marlen Yessirkepov
Publication date: 15-03-2024
Publisher: Springer Berlin Heidelberg
Keywords: Inflammatory Rheumatic Diseases
Erectile Dysfunction
Rheumatoid Arthritis
Osteoporosis
Osteoporosis
Fertility
Systemic Sclerosis
Benign Prostatic Hypertrophy
Benign Prostatic Hypertrophy
Systemic Lupus Erythematosus
Published in: Rheumatology International / Issue 5/2024
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-024-05549-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2024

Endorsement of reporting guidelines and clinical trial registration across Scopus-indexed rheumatology journals: a cross-sectional analysis

The prevalence of neutropenia and association with infections in patients with systemic lupus erythematosus: a Swedish single-center study conducted over 14 years

Quality indicators and satisfaction with care in patients with systemic lupus erythematosus

Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease

Pattern of disease expression in SLE patients with antiphospholipid antibodies: data from Indian Systemic Lupus Erythematosus Inception cohort (INSPIRE)

Nursing and allied health workforce in Australian public rheumatology departments is inadequate: a cross-sectional observational study

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage